to plan and engage customers more effectively
\n<\/em><\/p>\n
BARCELONA, Spain \u2014 9 Jun, 2020 \u2014 <\/strong> Today at Veeva Summit Online, Veeva Systems<\/a> (NYSE:VEEV) announced Veeva Link for KAM, a new solution that gives commercial and medical teams accurate customer data and real-time insights for key account management. Veeva Link for KAM brings together data and AI-driven insights on key people and key accounts from thousands of scientific and digital sources such as social media, news feeds, video platforms, industry conferences, and clinical trials, as well as Veeva CRM<\/a>. Commercial and medical teams can now adapt plans with greater agility, respond to customers faster, and develop much deeper relationships.<\/p>\n “It\u2019s critical that life sciences companies deeply understand the needs of health systems to support research and patient care,\u201d said Enrique Grande, head of oncology at MD Anderson Madrid Cancer Center. \u201cOur best partners can rapidly adapt to new challenges and mobilize their resources to support us and our patients.\u201d<\/p>\n Commercial and medical teams typically piece together key account information from a complex mix of stakeholders and data across many different channels. Veeva Link for KAM consolidates relevant insights on customer activities and relationships using AI so teams can quickly engage with the right people and decision-makers.<\/p>\n Customer data is constantly kept up to date through a combination of AI and Veeva data stewards. Advanced AI analyzes millions of activities in real-time, identifies patterns, and proactively delivers smart alerts for key account teams to stay better engaged with customers. With a curated feed of relevant insights on key people and key accounts, commercial organizations can respond fast to changing customer needs and deliver the right information to the right accounts at the right time.<\/p>\n Veeva Link for KAM can be used as a standalone product or with Veeva CRM. Seamless integration with Veeva CRM activity data provides account teams a complete understanding of who within the biopharma company has relationships with key people. This enables commercial and medical teams to drive the right follow-up and a more personalized customer journey.<\/p>\n \u201cCommercial agility is key to delivering greater customer value and, ultimately, improving patient outcomes,\u201d said Kilian Weiss, general manager for Veeva Link. \u201cVeeva Link for KAM will give key account teams the data, intelligence, and strategic insights they need to speed decision-making and tailor their customer engagement.\u201d<\/p>\n In other news today, Veeva announced a new capability in Veeva Vault PromoMats<\/a> to speed the digital submission of promotional materials for accelerated approval products. Read today\u2019s press release<\/a> to learn more.<\/p>\n Veeva Link for KAM is part of Veeva Link, a comprehensive set of solutions that brings together customer data, insights, and intelligence. Veeva Link Suite also includes Veeva Link for Oncology<\/a>, an enterprise data solution to centralize insights and intelligence on scientific leaders in oncology, and Veeva Link for You, an advanced data solution to provide strategic insights into scientific experts in specialty therapeutic areas.<\/p>\n Veeva Link for KAM is planned for availability by the end of 2020. Learn more about how Veeva is accelerating insights to key account teams at Veeva Summit Online<\/a>, 9-10 June. The event is only open to life sciences industry professionals. Register for the virtual event and on-demand sessions at veeva.com\/Summit<\/a>.<\/p>\n Additional Information<\/strong> About Veeva Systems<\/strong> Forward-looking Statements<\/strong> ###<\/p>\n![\"\"\/](\"https:\/\/www.veeva.com\/wp-content\/uploads\/2020\/06\/Veeva-Link-for-KAM.png\")
<\/a>
\nCommercial and medical teams get a curated feed of
AI-driven insights on key people and key accounts.<\/em><\/span>\n<\/div>\n
\nConnect with Veeva on LinkedIn: linkedin.com\/company\/veeva-systems<\/a>
\nFollow @veeva_eu on Twitter: twitter.com\/veeva_eu<\/a>
\nLike Veeva on Facebook: facebook.com\/veevasystems<\/a><\/p>\n
\nVeeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 875 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com\/eu<\/a>.<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended April 30, 2020. This is available on the company\u2019s website at veeva.com<\/a> under the Investors section and on the SEC\u2019s website at sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n